Féminin Sacré - Nouvelle Lune
Food supplement declared in France, declaration No 2023-8-328
Féminin Sacré - Nouvelle Lune (Ælixir Ælchimique) is a food supplement declared in France. Status: withdrawal from the market announced for 30 September 2028. Main ingredients: Artemisia vulgaris 335 mg per day, Salvia officinalis 206 mg per day, Achillea millefolium 129 mg per day, Rubus idaeus 60 mg per day, miel. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Ælixir Ælchimique
- Food business operator placing the product on the market
- VITURET Florent
- Status
- Withdrawal from the market announced for 30 September 2028
- Form
- Dropper
- Daily dose
- 90 gouttes soit 834mg d'extrait
- Directions for use
- 30 gouttes diluées dans un verre d'eau, 3 fois par jour pendant 3 semaines.
- Intended populations
- Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Taking anticoagulants, Taking antidepressants, Taking blood pressure medication, Taking medication, Taking thyroid medication, Prolonged use, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Menstrual cycles, Mood
Declaration 272221, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Artemisia vulgaris L. | Parties aériennes | Alcoolature | 335 mg |
| Salvia officinalis L. | Parties aériennes | Alcoolature | 206 mg |
| Achillea millefolium L. | Sommités fleuries | Alcoolature | 129 mg |
| Rubus idaeus L. | Jeune pousse | Autre macérât | 60 mg |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
| Eau de mer | not declared |
Other ingredients
Eau osmosée dynamisée, Alcool
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ce produit additionne les contre-indications de chacune des plantes qui le compose, il est donc contre-indiqué à la femme enceinte, allaitante, à l'enfant de moins de 18 ans et aux personnes aux antécédant de cancer hormonodépendant, de crises d'épilepsies ou sous traitement médicamenteux.Détail :L'Armoise commune est contre-indiquée à la femme enceinte, allaitante et à l'enfant de moins de 12 ans.La Sauge est contre-indiquée en cas d'antécédant de cancer hormonodépendant, déconseillée aux adolescents de moins de 18 ans, nécessite un avis médical en cas d'antécédant de crises d'épilepsies ou de prises d'anxiolytiques ou thymorégulateurs, nous la déconseillons à toutes personnes sous traitement médicamenteux par principe de précaution.. Son utilisation prolongée est déconseillée.L'Achillée Millefeuille nécessite un avis médical en cas de traitement anti-coagulant et attention aux allergies aux Astéracées.Le Framboisier n'ajoute aucune contre-indications supplémentaires.
Regulatory points
- Conditions légales
Artemisia vulgaris L.: L'huile essentielle de cette plante est interdite.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawal from the market announced for 30 September 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Artemisia vulgaris L.
Read the warning, when it applies and the studies cited
MUGWORT - ARTEMISIA VULGARIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Blumenthal et al. 1998; Williamson et al. 1988).
Sources cited by Health Canada (3)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Wichtl 2004; Hoffmann 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.
- Salvia officinalis L.
Read the warning, when it applies and the studies cited
SAGE - SALVIA OFFICINALIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
SAGE -SALVIA OFFICINALIS Oral
Cautions and warnings
Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Ælixir Ælchimique
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Féminin Sacré - Nouvelle Lune (Ælixir Ælchimique): composition and regulation”, https://compoatlas.com/en/supplements/products/272221-feminin-sacre-nouvelle-lune, updated 15 November 2026.